Mace Security International, Inc.(MACE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MACE Mace Security International, Inc.

休市中 12-19 16:00:00 EST 延时

{"stockData":{"symbol":"MACE","market":"US","secType":"STK","nameCN":"Mace Security International, Inc.","latestPrice":0.01568,"timestamp":1766178000000,"preClose":0.01568,"halted":0,"volume":0,"delay":15,"floatShares":61215490,"shares":66596075,"eps":-0.039075,"marketStatus":"休市中","change":0,"latestTime":"12-19 16:00:00 EST 延时","open":0.01568,"high":0.01568,"low":0.01568,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.039075,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.01568,"volumeRatio":0.10668023659160104},"requestUrl":"/m/hq/s/MACE","defaultTab":"news","newsList":[{"id":"2590518307","title":"未来已来，看口服司美如何重塑糖尿病的治疗价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2590518307","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590518307?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:37","pubTimestamp":1765355850,"startTime":"0","endTime":"0","summary":"第二代的长效及速效胰岛素联合应用，已成为糖尿病晚期管理的核心，但可能面临低血糖和体重增加等问题。“口服化”必然成为糖尿病治疗发展的新方向。在实现治疗便利性、且保证疗效的同时，口服司美格鲁肽在心血管保护和降低肾病风险方面的表现也引发业内关注。目前，2型糖尿病患者在降糖、降低心血管疾病及肾病风险方面的综合代谢治疗获益已经成为内分泌专业医生的治疗关注重点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MACE","BK4157","BK4183"],"gpt_icon":0},{"id":"2570909606","title":"告别针头！口服司美格鲁肽片实现16.6%体重减轻","url":"https://stock-news.laohu8.com/highlight/detail?id=2570909606","media":"医药地理","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570909606?lang=zh_cn&edition=full","pubTime":"2025-09-25 17:10","pubTimestamp":1758791432,"startTime":"0","endTime":"0","summary":"结果显示：在严格遵循治疗的患者中，口服司美格鲁肽片25 mg组体重降幅达16.6%，显著高于安慰剂组的2.7%；34.4%的受试者减重超过20%，而安慰剂组这一比例仅为2.9%。即使考虑部分患者用药依从性不足的情况，口服组仍实现13.6%的体重降幅，近30%的患者减重超过20%。其中，司美格鲁肽注射液表现尤为突出，单季度销售额高达8.16亿元，占据市场主导地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925182127a4433b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925182127a4433b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","MACE","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4588","BK4532","NVO","BK4599","BK4585","LU1093756325.SGD","BK4007","LU0154236417.USD","BK4157","LU1093756168.USD"],"gpt_icon":1},{"id":"2564823056","title":"上半年创新药对外授权近660亿美元；司美格鲁肽最新数据出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2564823056","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564823056?lang=zh_cn&edition=full","pubTime":"2025-09-02 07:59","pubTimestamp":1756771151,"startTime":"0","endTime":"0","summary":"政策动向国家药监局副局长徐景和：上半年创新药对外授权金额近660亿美元9月1日，国家药监局副局长徐景和在2025年“全国药品安全宣传周”启动仪式上表示，即将收官的“十四五”，是持续释放政策红利的五年，医药产业创新发展更加有为、更加有力。2025年上半年创新药对外授权总金额已接近660亿美元，全球市场对中国创新药的认可度正在不断提升。地方上，去年共抽检药品216164批次，不合格率0.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902080149a4ae467f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902080149a4ae467f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BK4157","MACE","BK4599","BK4588","LLY","BK4132","BK4585","O","LU0154236417.USD","IE00BZ1G4Q59.USD","NVO","BK4007","BK4183","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","AD","Y"],"gpt_icon":1},{"id":"2564807899","title":"在GLP-1（胰高血糖素样肽-1）减肥药的竞争中诺和诺德的司美格鲁肽终于凭借心血管方面的获益扳回一局。9月1日记者从诺和","url":"https://stock-news.laohu8.com/highlight/detail?id=2564807899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564807899?lang=zh_cn&edition=full","pubTime":"2025-09-01 14:33","pubTimestamp":1756708413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","GLP","LU1093756168.USD","BK4588","LU1093756325.SGD","IE00BKVL7J92.USD","BK4590","IE00BZ1G4Q59.USD","BK4183","BK4532","MACE","BK4144","LU0154236417.USD","BK4585","NVO","BK4157","BK4007"],"gpt_icon":0},{"id":"2564898466","title":"礼来Muvalaplin片启动III期临床 适应症为降低伴Lp(a)水平升高患者MACE发生风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2564898466","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564898466?lang=zh_cn&edition=full","pubTime":"2025-09-01 12:31","pubTimestamp":1756701060,"startTime":"0","endTime":"0","summary":"本次试验主要目的为在伴有Lp水平升高且发生过ASCVD事件或发生首次ASCVD事件风险升高的成人参与者中评价Muvalaplin对主要不良心血管事件影响。Muvalaplin片为化学药物，适应症为在伴Lp水平升高且已确诊CVD或发生首次CVE风险升高的患者中，降低MACE的发生风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901123802976f95b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901123802976f95b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1974910355.USD","BK4599","LLY","LU0114720955.EUR","LU2471134952.CNY","LU2602419157.SGD","LU1548497426.USD","SGXZ51526630.SGD","LU2746668461.USD","LU1267930730.SGD","LU2237438978.USD","LU1366192091.USD","SGXZ57979304.SGD","Y","LU2750360997.AUD","SG9999018865.SGD","LU0079474960.USD","LU0471298777.SGD","GB00BDT5M118.USD","LU1061106388.HKD","LU0672654240.SGD","LU2468319806.SGD","SGXZ99366536.SGD","LU0823434583.USD","LU0203201768.USD","LU0466842654.USD","LU1280957306.USD","LU2237443622.USD","SGXZ81514606.USD","LU0109391861.USD","LU2552382215.SGD","LU0122379950.USD","LU0354030511.USD","III","LU0385154629.USD","LU0256863902.USD","BK4588","LU0238689110.USD","LU0097036916.USD","LU0889565916.HKD","LU2746668974.SGD","LU0094547139.USD","MACE","LU0432979614.USD","LU2461242641.AUD","LU2237443549.SGD","LU2491050071.SGD","SG9999018857.SGD","LU1720051017.SGD","IE00B2B36J28.USD","LU0198837287.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.mace.com","stockEarnings":[{"period":"1week","weight":0.1046},{"period":"1month","weight":0.0148},{"period":"3month","weight":-0.1297},{"period":"6month","weight":-0.1401},{"period":"1year","weight":-0.1228},{"period":"ytd","weight":0.0257}],"description":"Manufacturer of personal defense products.","exchange":"OTCQB","name":"Mace Security International, Inc.","nameEN":"Mace Security International, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mace Security International, Inc.(MACE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mace Security International, Inc.(MACE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mace Security International, Inc.,MACE,Mace Security International, Inc.股票,Mace Security International, Inc.股票老虎,Mace Security International, Inc.股票老虎国际,Mace Security International, Inc.行情,Mace Security International, Inc.股票行情,Mace Security International, Inc.股价,Mace Security International, Inc.股市,Mace Security International, Inc.股票价格,Mace Security International, Inc.股票交易,Mace Security International, Inc.股票购买,Mace Security International, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mace Security International, Inc.(MACE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mace Security International, Inc.(MACE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}